These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6603979)

  • 1. Steady state disposition of chloroquine in patients with rheumatoid disease.
    Frisk-Holmberg M; Bergqvist Y; Domeij-Nyberg B
    Eur J Clin Pharmacol; 1983; 24(6):837-9. PubMed ID: 6603979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further support for changes in chloroquine disposition and metabolism between a low and a high dose.
    Frisk-Holmberg M; Bergqvist Y; Termond E
    Eur J Clin Pharmacol; 1985; 28(6):721-2. PubMed ID: 4065196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis.
    Augustijns P; Geusens P; Verbeke N
    Eur J Clin Pharmacol; 1992; 42(4):429-33. PubMed ID: 1307690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction.
    Bergqvist Y; Hed C; Funding L; Suther A
    Bull World Health Organ; 1985; 63(5):893-8. PubMed ID: 3879200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose and steady state pharmacokinetics of CSA and two main primary metabolites, AM1 and AM4n in patients with rheumatic/autoimmune diseases.
    Suchy D; Dostalek M; Perinova I; Brozmanova H; Grundmann M; Vyskocil V; Mayer O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):269-74. PubMed ID: 22286813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of renal insufficiency on the excretion of diverse drugs (chloroquine, sedatives, methacycline)].
    Fabre J; Rudhardt M; Duckert A; de Freudenreich J; Pitton JS
    Helv Med Acta Suppl; 1966 May; 46():132-3. PubMed ID: 5286254
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloroquine influences renal function in rural Zimbabweans with acute transient fever.
    Musabayane CT; Musvibe A; Wenyika J; Munjeri O; Osim EE
    Ren Fail; 1999 Mar; 21(2):189-97. PubMed ID: 10088179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of piroxicam.
    Verbeeck RK; Richardson CJ; Blocka KL
    J Rheumatol; 1986 Aug; 13(4):789-96. PubMed ID: 3490574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolism of chloroquine.
    Köppel C; Tenczer J; Ibe K
    Arzneimittelforschung; 1987 Feb; 37(2):208-11. PubMed ID: 3580025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical study of chloroquine therapy in rheumatic diseases. (1). Distribution of chloroquine in the body].
    Sugiyama T; Okazaki T; Zukui T
    Saishin Igaku; 1967 Sep; 22(9):2126-32. PubMed ID: 6082221
    [No Abstract]   [Full Text] [Related]  

  • 12. Residual chloroquine and metabolites in man as a sequel of previous chloroquine medications: a urinary excretion study and its significance.
    Essien EE; Ifudu ND
    J Trop Med Hyg; 1984 Jun; 87(3):131-6. PubMed ID: 6512905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of chloroquine and its three metabolites in human plasma, whole blood and urine by ion-pair high-performance liquid chromatography.
    Houzé P; de Reynies A; Baud FJ; Benatar MF; Pays M
    J Chromatogr; 1992 Feb; 574(2):305-12. PubMed ID: 1618964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials.
    Mackenzie AH
    Am J Med; 1983 Jul; 75(1A):40-5. PubMed ID: 6869410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chloroquine metabolism in the mono-oxygenase system of mouse liver microsomes].
    Sakharova OD; Chekhonadskikh TV; Komarova NI; Pankova TG
    Vopr Med Khim; 1986; 32(6):55-7. PubMed ID: 3811287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with chloroquine-induced retinopathy in rheumatic diseases.
    Araiza-Casillas R; Cárdenas F; Morales Y; Cardiel MH
    Lupus; 2004; 13(2):119-24. PubMed ID: 14995005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of and clinical response to salicylates in patients with rheumatoid disease.
    Günsberg M; Bochner F; Graham G; Imhoff D; Parsons G; Cham B
    Clin Pharmacol Ther; 1984 May; 35(5):585-93. PubMed ID: 6713771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drug induced decrease in creatinine clearance.
    Landewé RB; Vergouwen MS; Goeei The SG; Van Rijthoven AW; Breedveld FC; Dijkmans BA
    J Rheumatol; 1995 Jan; 22(1):34-7. PubMed ID: 7699677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine metabolism in man: urinary excretion of 7-chloro-4-hydroxyquinoline and 7-chloro-4-aminoquinoline metabolites.
    Brown ND; Poon BT; Chulay JD
    J Chromatogr; 1985 Nov; 345(1):209-14. PubMed ID: 3841350
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.